Результати пошуку
- Фільтрувати за фондом:
- Всі
- Патенти України на винаходи
- Патенти України на корисні моделі
- Патенти України на промислові зразки
- Патенти на винаходи зарубіжних країн
- Заявки на винаходи
- Свідоцтва на топографії ІМС
- Свідоцтва України на знаки для товарів та послуг
- Прийняті до розгляду заявки на знаки для товарів і послуг
- Кваліфіковані зазначення походження товарів (КЗПТ)
| № п/п |
Номер патенту |
Назва винаходу та фрагмент реферату | Дата публікації патента |
|---|---|---|---|
| 1 | JP2001086119A |
METHOD AND SYSTEM DISPLAYING INFORMATION FOR USER AND COMPUTER PROGRAM PRODUCT
PROBLEM TO BE SOLVED: To provide an enhanced visual interface for a user in a management level of a network among hierarchical networks such as an SDH or SONET network or of a sub network management level. SOLUTION: A virtual display unit exhibits a map denoting a network element and connection between network elements so as to display network information for a user connected to a network of hiera... |
30.03.2001 |
| 2 | JP2001086370A |
DEVICE FOR CORRECTING IMAGE QUALITY
PROBLEM TO BE SOLVED: To provide a jitter detection device for a video signal which can accurately detect the jitter quantity of jitters of the video signal. SOLUTION: This jitter-detecting device 22, detects jitters of a video signal Sv measures a vertical time (Stf (v)) of one field (v) of the signal Sv and decides whether the signal Sv is subjected to jitters, on the basis of a vertical time si... |
30.03.2001 |
| 3 | JP2001086410A |
METHOD AND DEVICE FOR CONTROLLING DYNAMIC RANGE OF CIGITAL DIAGNOSTIC IMAGE
PROBLEM TO BE SOLVED: To detect and control an improved dynamic range by generating a display map defining the relation between the dynamic range of an original medical image representing a patient and a target dynamic range and preparing an image having the target dynamic range based on the display map and the original medical image. SOLUTION: An image acquisition workstation 10 further includes ... |
30.03.2001 |
| 4 | FR2760646B1 |
MATIERE DE PROTHESE POUR OS ET PROCESSUS POUR LA PRODUCTION DE CETTE DERNIERE
A prosthetic bone material comprising a bonded and sintered product of granules of calcium phosphate compound having a particle size of at least 100 mum, each of the granules being bonded with particulates of calcium phosphate compound having a particle size of about 1 to 40 mum, in which the granules are bonded to each other while retaining their original shape, and their bonding strength is a le... |
30.03.2001 |
| 5 | FR2798867A1 |
DEVICE FOR INJECTING FLUIDS SIMULTANEOUSLY INTO MICROFLUIDIC SYSTEM FOR BIOCHEMICAL REACTIONS HAS LAYER WITH DEFORMABLE SMALL DIAMETER, OPEN ENDED PIPES AND DEVICE FOR PRESSURIZING FLUIDS IN PIPES;DISPOSITIF DE DISTRIBUTION DE FLUIDES DANS UN MICROSYSTEME FLUIDIQUE
A device for injecting fluids simultaneously into a microfluidic system has a layer with deformable small diameter open ended pipes and a device for pressurizing the fluids to drive them through the pipes and into the system that is adjacent the open pipe ends. An Independent claim is included for injecting fluids into a microfluidic system.; La présente invention concerne un dispositif pour i... |
30.03.2001 |
| 6 | FR2798872A1 |
LOW VOLUME FRACTION METAL MATRIX PREFORMS FABRICATION COMPRISES MIXING REINFORCEMENT WITH SACRIFICIAL FILLERS, BINDER AND LIQUID, CURING RESULTING MOLDABLE SLURRY AND FIRING;PREFORMES DE FAIBLE FRACTION VOLUMIQUE POUR COMPOSITES A MATRICE METALLIQUE
Low volume fraction preform fabrication for a metal matrix composite comprises: mixing reinforcement with sacrificial fillers, binder and liquid to form a slurry, curing the slurry in a mold and firing the resulting green preform. The green preform is fired in a furnace controlled to provide a preform under combinations of time and temperature in a continuous sequence. The sequence comprises: (a) ... |
30.03.2001 |
| 7 | FR2798924A1 |
PROCEDE D'ELIMINATION DE LA MATIERE ORGANIQUE REFRACTAIRE AU TRAITEMENT BIOLOGIQUE
Ce procédé est caractérisé en ce que l'on soumet ladite matière organique à une oxydation chimique qui est réalisée simultanément au traitement biologique. L'invention vise également une installation comprenant un bassin biologique (2) recevant l'eau à traiter et dans lequel est maintenue la concentration souhaitée en biomasse et un bio-réacteur à membranes (6) caractérisée en ce qu'elle compor... |
30.03.2001 |
| 8 | FI106727B1 |
TRANSFORMOIDUT E. COLI- TAI CORYNE-BAKTEERIEN KANNAT JA NÄIDEN VALMISTUSMENETELMÄT;TRANSFORMERADE E. COLI- ELLER CYRONE-BAKTERIESTAMMAR OCH DERAS FRAMSTÄLLNINGSFÖRFARANDE
A tryptophan producing strain of microorganism is selected from E. coli and Corynebacteria and is tryptophan feedback resistant and serine feedback resistant. The serine feedback resistance is by a mutation in a serA allele, where the mutated serA allele codes for a protein which has a Ki value for serine between 0.1 mM and 50 mM. The tryptophan feedback resistance is by a trpE allele which codes ... |
30.03.2001 |
| 9 | BG63074B1 |
ANTISTRESS MEDICAMENTS AND FUNCTIONAL FOODS HAVING ANTISTRESS EFFECT;ЛЕКАРСТВА ПРОТИВ СТРЕС И ФУНКЦИОНАЛНИ ХРАНИ ПРИТЕЖАВАЩИ ПРОТИВОСТРЕСОВИ ЕФЕКТИ
The invention relates to an antistress agent and functional food containing it. The food can be accepted frequently and daily without any health risks, and it can ease or prevent mental and physical symptoms cased by stress. The food includes fermented yoghourt as an effective component produced, for example, by the fermentation of animal milk as initial material with lactic acid bacteria of the L... |
30.03.2001 |
| 10 | BG104416A |
(1R, 2S,4R)-(-)-2-[(2'-{N,N-DIMETHYLAMINO}-ETHOXY)]-2- [PHENYL]-1,7,7-TRI-[METHYL]-BICYCLO[2.2.1]HEPTANE OF HIGH PURITY AND ITS PHARMACEUTICALLY ACCEPTABLE WITH ACID SALTS, METHOD FOR THE PREPARATION OF THE COMPOUNDS AND MEDICAMENTS CONTAINING ONE OR MORE OF THEM AND THEIR USE;(1R,2S,4R)-(-)-2-[(2'-{N,N-ДИМЕТИЛАМИНО}-ЕТОКСИ)]-2-[ФЕНИЛ] -1,7,7-ТРИ-[МЕТИЛ]-БИЦИКЛО[2.2.1]ХЕПТАН С ВИСОКА ЧИСТОТА И НЕГОВИ ФАРМАЦЕВТИЧНО ПРИЕМЛИВИ С КИСЕЛИНА СОЛИ, МЕТОД ЗА ПОЛУЧАВАНЕТО НА СЪЕДИНЕНИЯТА И ЛЕКАРСТВА, СЪДЪРЖАЩИ ЕДНО ИЛИ ПОВЕЧЕ ОТ ТЯХ, И ИЗПОЛЗВАНЕТО ИМ
The invention relates to (1R, 2S, 4R)-(-)-2[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri- [methyl]-bicyclo[2.2.1]heptane of high purity and its pharmaceutically acceptable with acid salts, containing no more than 0.2% (1R, 3S, 4R)-3-[(2'-{N,N-dimethylamino}ethyl)]-1,7,7-tri-[methyl]-bicyclo [2.2.1]heptan-2-on , and/or its pharmaceutically acceptable with acid salt. The invention also rela... |
30.03.2001 |
| 11 | BG104417A |
METHOD FOR THE PREPARATION OF (1R, 2S, 4R)-(-)-2-[(2'-{N,N-DIMETHYLAMINO}-ETHOXY)]-2-{PHENYL]- 1,7,7-TRI-[METHYL]-BICYCLO[2.2.1]HEPTANE AND ITS PHARMACEUTICALLY ACCEPTABLE WITH ACID SALTS;МЕТОД ЗА ПОЛУЧАВАНЕ НА
The invention relates to a method for the preparation of (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7, 7-tri-[methyl]-bicyclo[2,2,1]heptane and its pharmaceutically acceptable with acid salts of higher yields and increased degrees of purity. 10 claims |
30.03.2001 |
| 12 | NZ337038A |
PURIFIED CALCAREOUS MATERIAL AND ITS USE FOR TREATING CONDITIONS CREATED BY A FAILURE OF IMMUNO REGULATION IN THE BODY
Calcareous materials which are purified residues of corallinaceae particularly Lithothamnium corallioides have therapeutic properties including treatment of conditions created by failure of immune regulation for example rheumatoid or osteoarthritis, osteoporosis and other conditions involving pH control. Compositions of the purified residues together with fatty acids, glycerides, polyglycols and e... |
30.03.2001 |
| 13 | JP2001085767A |
ELECTRO-OPTICAL SYSTEM BASED ON MICROLASER AND MANUFACTURING METHOD THEREOF
PROBLEM TO BE SOLVED: To provide an electro-optical system, comprising a primary heat sink and at least one submount mounted on the heat sink. SOLUTION: This system comprises a pump source, such as a laser diode attached to the sidewall of at least one submount 18a, 18b, a secondary heat sink 27 mounted on at least one submount containing an active gain medium 14 which extends as a cantilever from... |
30.03.2001 |
| 14 | JP2001086004A |
VARIABLE LENGTH CODING METHOD AND DEVICE
PROBLEM TO BE SOLVED: To decode a coded bit pattern by analyzing the occurrence statistics of symbols to the previous frames, setting the mapping relation again and executing the variable length coding to the current macro block. SOLUTION: A statistic analysis part 202 inputs symbols and calculates the occurrence statistics of an input symbol ai in the previous frames. A mapping part 204 relocates... |
30.03.2001 |
| 15 | GR3035045T3 |
RAPIDLY DISINTEGRATING PHARMACEUTICAL DOSAGE FORM AND PROCESS FOR PREPARATION THEREOF.
The present invention relates to a compressed pharmaceutical dosage form containing pharmaceutical particles coated with a taste-masking composition, a water-disintegratable, compressible carbohydrate and a binder. These components are dry blended and compressed into a dosage form, such as a tablet, having a hardness sufficient to cause the carbohydrate to disintegrate within 30 seconds after oral... |
30.03.2001 |
| 16 | FR2789678B1 |
ELEMENT DE CONSTRUCTION A BASE DE PLATRE RESISTANT A L'EAU, ET PROCEDE DE FABRICATION
A process of manufacturing at least a portion of a plaster-based water resistant construction element including the steps of :mixing together a dry material comprising at least a major portion of hydratable calcium sulfate, a water repellency agent, and hydrating water to form a homogenous mixture; preforming in the wet state the said portion of said construction element, from said homogeneous mix... |
30.03.2001 |
| 17 | FR2789679B1 |
ELEMENT DE CONSTRUCTION PREFABRIQUE A BASE DE PLATRE, PRESENTANT UNE RESISTANCE A L'EAU
A water-resistant prefabricated structural element comprising a substrate based on cured plaster, said substrate being able to be obtained by at least the following steps:(a) homogeneously mixing a dry material, comprising mostly at least one hydratable calcium sulfate, a water-repellent agent comprising at least one silicone compound, and water and preforming said substrate in the wet state;(b) d... |
30.03.2001 |
| 18 | PT734701E |
ARTICULACAO ARTIFICIAL
Artificial joint, in particular an endoprothesis for the human knee joint, consisting of at least two joint parts moving with respect to each other, a joint head and a joint base, with toroidal joint surfaces, that have function surfaces with differing circular intersection contours in mutually perpendicular planes-a longitudinal plane and a transverse plane-whereby the curve ratios of the functio... |
30.03.2001 |
| 19 | PL180652B1 |
NOVEL PEPTIDIC ACTIVE SUBSTANCE AND METHOD OF OBTAINING SAME
PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity. |
30.03.2001 |
| 20 | NZ335993A |
NON-AZEOTROPIC REFRIGERANT COMPOSITION
Provided is a non-azeotropic refrigerant composition having a vapour pressure at -20oC of from 70 to 190kPa, at +20oC of from 510 to 630kPa and at +60oC of from 1620 to 1740 kPa, which composition comprises: 1 From 60 to 99% by weight of 1,1,2,2-tetrafluoroethane (R134), 1,1,1,2-tetrafluoroethane (R134a), difluromethoxytrifluoromethane (E125) or a mixture of two or more of these; 2 From 1 to 10% b... |
30.03.2001 |